Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer [Phase 3]
Clinical trial update for a Phase 3 study evaluating 18F-Florastamin PET/CT imaging in patients with at least intermediate risk prostate can…
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer [Phase 1]
Phase 1 clinical trial evaluating PSCA-CAR T cells in PSCA-positive metastatic castration-resistant prostate cancer; study is active not rec…
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: Brachytherapy for Recurrent Prostate Cancer [Phase 2]
Phase 2 clinical trial update on brachytherapy for recurrent prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients [NA]
Clinical trial update for multi-parametric MRI in prostate cancer was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update for GTx-758 in men with castration-resistant prostate cancer; study terminated with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: Tracer-Guided Surgery for Recurrent Prostate Cancer [Phase 2]
Phase 2 clinical trial update for tracer-guided surgery in recurrent prostate cancer.
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer [Phase 2]
Phase 2 clinical trial update for a multivalent conjugate vaccine in biochemically relapsed prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer [Phase 3]
Phase 3 trial evaluating niraparib in combination with abiraterone acetate and prednisone versus abiraterone acetate and prednisone for meta…
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: COMbination of Bipolar Androgen Therapy and Nivolumab [Phase 2]
Phase 2 trial evaluating the combination of Bipolar Androgen Therapy with Nivolumab in prostate cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating enzalutamide with or without vaccine therapy in advanced prostate cancer has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: Copper-64 SAR Bombesin in PSMA Negative Prostate Cancer (BOP) [Phase 2]
Phase 2 clinical trial of Copper-64 SAR Bombesin in PSMA-negative prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating androgen deprivation combined with docetaxel and enzalutamide for metastatic prostate cancer; resul…
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation [Phase 2]
A completed Phase 2 trial evaluating beta-hydroxy-beta-methylbutyrate (HMB) to counteract muscle loss in men with prostate cancer receiving …
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 study of AZD8186, a PI3K-β inhibitor, in combination with docetaxel for patients with PTEN or PIK3CB-mutant advanced solid tumors, i…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Study of 18F-Thretide PET/CT in Patients With Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing 18F-Thretide PET/CT imaging in patients with prostate cancer has completed.
-
FDA approval · 2023-09-19FDA Approved: DOCETAXEL — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal's supplemental application to manufacture and market a generic docetaxel, enabling its supply for cancer treatment i…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Postoperative Pain in Laparoscopic Radical Prostatectomy Surgery With Tranexamic Acid: Analgesia? Hiperalgesia? [Phase 4]
A Phase 4 clinical trial update exploring postoperative pain management after laparoscopic radical prostatectomy using tranexamic acid for a…
-
FDA approval · 2023-09-15FDA Approved: DOCETAXEL — Supplemental Application (Gland Pharma Limited)
FDA approved a supplemental application for docetaxel from Gland Pharma Limited under an ANDA for the generic product.
-
CLINICAL_TRIALS withdrawal · 2023-09-14Clinical Trial Update: Darolutamide With Radium-223 or Placebo and the Effect on Radiological Progression-Free Survival for Patients With mCSPC [Phase 3]
Phase 3 trial investigating darolutamide with radium-223 or placebo in metastatic castration-resistant prostate cancer was withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy [Phase 1, Phase 2]
A clinical trial evaluating ipatasertib or apitolisib with abiraterone acetate versus abiraterone alone in previously treated castration-res…
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: Non-systemic Treatment for Patients With Low-volume Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating a non-systemic treatment for patients with low-volume metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial update for HRS-4357 in patients with advanced prostate cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer [Phase 2]
Phase 2 clinical trial assessing dutasteride's effect on androgen-response gene expression in patients with advanced prostate cancer has com…
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Soccer Intervention in Prostate Cancer Survivors [NA]
Completed clinical trial evaluating a soccer intervention for prostate cancer survivors; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Prostate Medication, Metabolism and Gut Microbiota [Phase 4]
Phase 4 clinical trial update investigating a prostate medication's metabolism and gut microbiota effects in prostatic hyperplasia and prost…